Wednesday, February 10, 2010, 3:17pm SGT - The Singapore stock market closes in 1 hour and 43 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Valeant Pharmaceuticals International (VRX)

At 5:02AM SGT: 35.55 USD  Up 1.06 (3.07%)  
 MORE ON VRX 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 VALEANT PHARMA INTL (NYSE:VRX) Delayed quote dataEdit
After Hours: 35.55 0.00 (0.00%) as of 5:31am SGT on 02/10/10
Last Trade:35.55 USD
Trade Time:5:02AM SGT
Change:Up 1.06 (3.07%)
Prev Close:34.49
Open:34.76
Bid:N/A
Ask:N/A
1y Target Est:27.50
Day's Range:34.56 - 35.69
52wk Range:15.64 - 35.80
Volume:811,879
Avg Vol (3m):677,422
Market Cap:2.89B
P/E (ttm):N/A
EPS (ttm):-0.64
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add VRX to Portfolio   Download Data

 HEADLINES 
•Valeant Pharmaceuticals to Announce 2009 Fourth Quarter and Year Results on February 22, 2010
PR Newswire (Mon, Feb 8)
•Coverage initiated on Valeant Pharmaceuticals by Jefferies & Co
Briefing.com (Fri, Feb 5)
•3 Stocks Ready to Roar
at Motley Fool (Wed, Jan 20)
•VALEANT PHARMACEUTICALS INTERNATIONAL Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Mon, Jan 11)
•Valeant Pharmaceuticals to Hold Conference Call to Announce 2010 Financial Guidance scheduled for 9:00 am ET today
CCBN (Fri, Jan 8)
•Valeant Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
PR Newswire (Wed, Jan 6)
•Valeant Pharmaceuticals to Hold Conference Call to Announce 2010 Financial Guidance
PR Newswire (Wed, Jan 6)
•Valeant Drug Accepted by FDA
Zacks.com (Mon, Jan 4)
•Aetna, Nvidia, MGM Mirage, Compugen are movers
AP (Thu, Dec 31)
•Valeant: Regulators review retigabine applications
AP (Wed, Dec 30)
•FDA Accepts NDA Filing for Retigabine
PR Newswire (Wed, Dec 30)
More Headlines for VRX...
 ANALYST 
EPS Est (next year) (Dec-09) :2.14
EPS Est (in 2 years) (Dec-10) :2.50
Avg Rec (current)*:3.6
PEG Ratio:0.77
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Valeant Pharmaceuticals International, a specialty pharmaceutical company, engages in the development, manufacture, and marketing of a range of pharmaceutical products.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices